FR2662939A1 - Anti-inflammatory gel and process for producing it - Google Patents

Anti-inflammatory gel and process for producing it Download PDF

Info

Publication number
FR2662939A1
FR2662939A1 FR9007158A FR9007158A FR2662939A1 FR 2662939 A1 FR2662939 A1 FR 2662939A1 FR 9007158 A FR9007158 A FR 9007158A FR 9007158 A FR9007158 A FR 9007158A FR 2662939 A1 FR2662939 A1 FR 2662939A1
Authority
FR
France
Prior art keywords
mixture
weight
purified water
grams
excipient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR9007158A
Other languages
French (fr)
Other versions
FR2662939B1 (en
Inventor
Beaussier Yann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR9007158A priority Critical patent/FR2662939B1/en
Publication of FR2662939A1 publication Critical patent/FR2662939A1/en
Application granted granted Critical
Publication of FR2662939B1 publication Critical patent/FR2662939B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Birds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

A non-fatty anti-inflammatory gel is prepared by bringing a mixture of dermatophilic excipient to 90 DEG C as well as purified water to which sodium methyl parabenzoate is added, and mixing at this temperature one part by weight of the first with 2.75 parts by weight of the second, allowing this product to cool to 60 DEG C and adding at this temperature 6 % by weight of a mixture of essential oils having an analgesic and antiseptic effect; and allowing the whole to cool, skimming off the surface to expose the clear gel.

Description

La présente invention concerne une substance pharmaceutique anti-inflammatoire du type gel destinée à être appliquée localement sur la zone du corps à traiter et son procédé de fabrication. The present invention relates to an anti-inflammatory pharmaceutical substance of the gel type intended to be applied locally to the area of the body to be treated and to its manufacturing process.

Certaines affections douloureuses d'origines musculaires et/ou articulaires (entorses, foulures, claquages ou déchirures musculaires, torticolis ) peuvent être atténuées par l'application de principes actifs se présentant sous la forme d'huiles essentielles ayant des propriétés antinévralgiques et antispasmodiques. Certain painful affections of muscular and / or articular origins (sprains, strains, muscle breakdowns or tears, torticollis) can be alleviated by the application of active ingredients in the form of essential oils having anti-neuralgic and antispasmodic properties.

Ces huiles ont souvent en plus des propriétés aseptisantes et cicatrisantes. These oils often have in addition sanitizing and healing properties.

On a donc pensé associer un certain nombre de ces huiles pour regrouper leurs propriétés en un produit unique capable d'agir sur une douleur musculaire ou articulaire et/ou sur une plaie ou brûlure, ayant constaté que dans de nombreux cas la plaie était souvent accompagnée d'une douleur de ce type. We therefore thought of associating a certain number of these oils to group their properties into a single product capable of acting on muscle or joint pain and / or on a wound or burn, having found that in many cases the wound was often accompanied of this kind of pain.

Par ailleurs, le mode d'action d'une telle substance conduit également à l'utiliser pour l'échauffement musculaire avant un effort sportif. Furthermore, the mode of action of such a substance also leads to using it for muscle heating before a sporting effort.

C'est donc dans cet esprit que l'invention fut mise au point. C'est-à-dire fabriquer une substance qui contienne des huiles essentielles ayant des effets dans les trois domaines (antalgie, aseptie, échauffement3 et ayant un aspect agréable sous la forme d'un gel transparent non gras. It is in this spirit that the invention was developed. That is to say, to manufacture a substance which contains essential oils having effects in the three areas (analgesic, aseptic, heating3 and having a pleasant appearance in the form of a non-greasy transparent gel.

A cet effet donc, l'invention a pour premier objet une substance pharmaceutique pour application cutanée qui comprend pour un litre
- 60 à 80 grammes d'huiles essentielles comportant cinq constituants : cajeput, menthe poivrée, lavande, eucalyptus, romarin à parts égales,
- Environ 250 grammes d'excipients comprenant trois constituants : un polyglycoléther d'alcool gras pour 62 % en poids, un décylester d'acide oléique pour 36,5 % en poids et un 2-octyl-dodécanol pour le reste,
- de l'eau purifiée à titre de complément.
For this purpose therefore, the invention firstly relates to a pharmaceutical substance for skin application which comprises, for one liter
- 60 to 80 grams of essential oils comprising five constituents: cajeput, peppermint, lavender, eucalyptus, rosemary in equal parts,
- About 250 grams of excipients comprising three constituents: a fatty alcohol polyglycol ether for 62% by weight, an oleic acid decylester for 36.5% by weight and a 2-octyl-dodecanol for the rest,
- purified water as a supplement.

Le choix de ces cinq huiles essentielles a été retenu pour leurs propriétés aseptisantes, antalgiques et antinévralgiques qui sont bien connues, afin de réaliser un produit anti-inflammatoire. The choice of these five essential oils was chosen for their aseptic, analgesic and anti-neuralgic properties which are well known, in order to produce an anti-inflammatory product.

De manière préférée, l'eau purifiée est additionnée de para oxybenzoate méhtyle sodé à raison de 2,2 pour mille en poids. Preferably, the purified water is added with sodium methyl para-oxybenzoate in an amount of 2.2 per thousand by weight.

Enfin, la substance comporte en outre un colorant du type jaune méthyle orangé en quantité suffisante. Finally, the substance also contains a dye of the orange-yellow methyl type in sufficient quantity.

Un second objet de la présente invention consiste en un procédé pour la préparation de la substance précédente sous la forme d'un gel anti-inflammatoire non gras. Ce procédé comporte les phases suivantes
- porter le mélange d'excipient à l'état liquide à la température de 900C,
- chauffer l'eau purifiée à 900C,
- incorporer à cette température l'excipient dans l'eau en évitant la formation de bulles d'air,
- laisser refroidir le mélange jusqu'à 600C,
- incorporer le mélange d'huiles porté à 600C dans le mélange précédent et
- écrémer le mélange résultant au cours de son refroidissement avant la prise du gel.
A second object of the present invention consists of a process for the preparation of the above substance in the form of a non-fatty anti-inflammatory gel. This process includes the following phases
- bring the mixture of excipient in the liquid state to the temperature of 900C,
- heat the purified water to 900C,
- incorporate the excipient at this temperature in the water, avoiding the formation of air bubbles,
- allow the mixture to cool to 600C,
- incorporate the mixture of oils brought to 600C in the preceding mixture and
- skim the resulting mixture during its cooling before setting the gel.

Pour parfaire la limpidité du gel, le procédé comporte une phase supplémentaire de réchauffage du mélange final suivie d'un écrémage supplémentaire. To perfect the clarity of the gel, the process comprises an additional phase of reheating the final mixture followed by additional skimming.

On rappellera que l'essence de cajeput, qui est un arbre abondant aux Philippines, en Malaisie, aux
Moluques et dans les Iles Célèbes comprend essentiellement les constituants suivants : Cinéol (60 à 75 % ), Pinène gauche, Terpinéol et des Aldéhydes. Ses propriétés en font un antiseptique général, un antinévralgique et un antispasmodique à usage externe.
It will be recalled that the essence of cajeput, which is an abundant tree in the Philippines, in Malaysia, in
Moluccas and the Celebes Islands essentially includes the following constituents: Cineol (60 to 75%), Left Pinene, Terpineol and Aldehydes. Its properties make it a general antiseptic, a neuralgic and an antispasmodic for external use.

La menthe poivrée (ou menthe anglaise) comporte les constituants essentiels suivants
Menthol (30 à 70 %), terpène, menthène, phellandrène, limonène, une acétone (menthone) et du tanin.
Peppermint (or English mint) has the following essential constituents
Menthol (30 to 70%), terpene, mint, phellandrene, limonene, acetone (menthone) and tannin.

Outre ses propriétés antalgiques et antispetiques ce produit, en usage externe, est un parasiticide. In addition to its analgesic and antispetic properties, this product, for external use, is a parasiticide.

La lavande est utilisée en usage externe pour les plaies de toutes natures et les brûlures, de même que l'essence d'Eucalyptus qui possède un pouvoir bactéricide. Lavender is used externally for wounds of all kinds and burns, as is the essence of Eucalyptus which has a bactericidal power.

Le romarin comporte des constituants semblables et est indiqué en usage externe comme cicatrisant et résolutif de plaies, brûlures, rhumatismes et douleurs musculaires. Rosemary has similar components and is indicated for external use as healing and resolving wounds, burns, rheumatism and muscle pain.

A titre indicatif on rapportera que 250 millilitres de la substance selon l'invention comprennent 3,07 g de chaque huile essentielle. As an indication, it will be reported that 250 milliliters of the substance according to the invention comprise 3.07 g of each essential oil.

Pour ce qui concerne les excipients on a choisi a) EUMULGIN B1, nom commercial d'un polyglycoléther d'alcools
gras saturé du type lanette O qui se présente sous la
forme d'une masse blanche ou légèrement jaune. Il s'agit
d'un émulgateur non ionique spécialement indiqué pour
émulsionner des huiles, des cires minérales, des hydro
carbures, des solvants, des huiles végétales et graisses
animales.
With regard to the excipients, we have chosen a) EUMULGIN B1, trade name of a polyglycolether of alcohols
saturated fat type lanette O which appears under the
form of a white or slightly yellow mass. It's about
a non-ionic emulsifier specially indicated for
emulsify oils, mineral waxes, hydro
carbides, solvents, vegetable oils and fats
animal.

b) CETIOL V, nom commercial d'un décylester d'acide oléique
est un liquide huileux faiblement jaunâtre s'apparentant
aux graisses de la peau et très dermatophile. C'est
un produit stable dans le temps. Sa miscibilité avec
de nombreux corps gras en fait un véhicule intéressant
pour de nombreux produits actifs lipo-solubles.
b) CETIOL V, trade name of an oleic acid decylester
is a slightly yellowish oily liquid akin to
with skin fats and very dermatophilic. This is
a stable product over time. Its miscibility with
many fatty substances make it an interesting vehicle
for many liposoluble active products.

c) EUTANOL G, nom commercial d'un 2-octyl-dodécanol, produit
de condensation d'alcools gras saturés à prédominance
d'alcool décylique fabriqué par réaction Guerbet.
c) EUTANOL G, trade name of a 2-octyl-dodecanol, product
condensation of predominantly saturated fatty alcohols
decyl alcohol produced by Guerbet reaction.

Ce produit, très dermatophile, pénètre bien dans la
peau et constitue un excellent solvant pour les produits
actifs liposolubles. Il est stable et peut être facilement
parfumé.
This very dermatophilic product penetrates well into the
skin and is an excellent solvent for products
liposoluble active ingredients. It is stable and can be easily
fragrant.

Dans les 250 ml du produit final ci-dessus, on aura un excipient comportant 38,5 g d'EUMULGIN, 22,68 g de
CETIOL V et 1,01 g EUTANOL G.
In the 250 ml of the final product above, there will be an excipient comprising 38.5 g of EUMULGIN, 22.68 g of
CETIOL V and 1.01 g EUTANOL G.

Ces constituants seront complétés par 171,36 g d'eau purifiée additionnée de 0,38 g de para oxybenzoate methyle sodé. These constituents will be supplemented with 171.36 g of purified water added with 0.38 g of sodium methyl para-oxybenzoate.

Le procédé selon l'invention tel que décrit ci-dessus est nécessaire à l'obtention d'un gel clair. The process according to the invention as described above is necessary for obtaining a clear gel.

En effet, un simple mélange des constituants à une température quelconque ne conduit qu a une masse opaque rejetant les huiles essentielles.Indeed, a simple mixture of the constituents at any temperature leads only to an opaque mass rejecting essential oils.

La réunion à 600C des huiles au mélange excipient- eau donne un aspect crémeux au produit résultant. Combining the oils with the excipient-water mixture at 600C gives a creamy appearance to the resulting product.

On a également constaté que porter les huiles à une température supérieure à 60 C provoque leur altération. It has also been found that bringing the oils to a temperature above 60 ° C causes them to deteriorate.

Il est tout à fait nécessaire par ailleurs de "laisser refroidir" le produit à partir de 6O0C plutôt que d'en forcer le refroidissement qui provoque l'apparition de particules en suspension rendant le gel opaque. En revanche, un refroidissement naturel amène ces particules se formant lentement à se grouper en surface sous forme d'une crème qu'il est aisé de séparer du gel limpide.It is also quite necessary to "let cool" the product from 6O0C rather than forcing the cooling which causes the appearance of suspended particles making the gel opaque. On the other hand, natural cooling causes these slowly forming particles to group on the surface in the form of a cream which it is easy to separate from the clear gel.

Cette limpidité est améliorée par un réchauffage suivi d'un refroidissement doux de la substance finale, avec un écrèmage supplémentaire.  This clarity is improved by reheating followed by gentle cooling of the final substance, with additional creaming.

Claims (5)

REVENDICATIONS 1. Substance pharmaceutique pour application cutanée caractérisé en ce qu'elle comprend pour un litre 1. Pharmaceutical substance for skin application characterized in that it comprises for one liter - 60 à 80 grammes d'huiles essentielles comportant cinq constituants : cajeput, menthe poivrée, lavande, eucalyptus, romarin, à raison de 12,28 grammes chacun, - 60 to 80 grams of essential oils comprising five constituents: cajeput, peppermint, lavender, eucalyptus, rosemary, at a rate of 12.28 grams each, - environ 250 grammes d'excipients comprenant trois constituants : un polyglycoléther d'alcool gras pour 62 % en poids, un décylester d'acide oléique pour 36,5 % en poids et un 2-octyl-dodécanol pour le reste, - approximately 250 grams of excipients comprising three constituents: a polyglycolether of fatty alcohol for 62% by weight, a decylester of oleic acid for 36.5% by weight and a 2-octyl-dodecanol for the rest, - de l'eau purifiée à titre de complément. - purified water as a supplement. 2. Substance selon la revendication 1 caractérisée en ce que l'eau purifiée est additionnée de paraoxybenzoate méthyle sodé à raison de 2,2 pour mille en poids. 2. Substance according to claim 1 characterized in that the purified water is added with sodium methyl paraoxybenzoate in an amount of 2.2 per thousand by weight. 3. Substance selon la revendication 1 ou la revendication 2 caractérisée en ce qu'elle comporte un colorant du type jaune méthyle orangé. 3. Substance according to claim 1 or claim 2 characterized in that it comprises a dye of the orange yellow methyl type. 4. Procédé de préparation de la substance pharmaceutique selon la revendication 1, caractérisé en ce qu'il comporte les phases suivantes 4. Method for preparing the pharmaceutical substance according to claim 1, characterized in that it comprises the following phases - porter le mélange d'excipient à llétat liquide à la température de 900C, - bring the mixture of excipient in the liquid state to the temperature of 900C, - chauffer l'eau purifiée à 90 C,  - heat the purified water to 90 C, - incorporer à cette température l'excipient dans l'eau en évitant la formation de bulles d'air - incorporate the excipient at this temperature in the water, avoiding the formation of air bubbles - laisser refroidir le mélange jusqu'à 600C, - allow the mixture to cool to 600C, - incorporer le mélange d'huiles porté à 600C (éventuellement additionné de colorant) dans le mélange précédent et, - incorporate the mixture of oils brought to 600C (possibly supplemented with dye) in the preceding mixture and, - écrémer le mélange résultant au cours de son refroidissement avant la prise du gel. - skim the resulting mixture during its cooling before setting the gel. 5. Procédé selon la revendication 4 caractérisé en ce qu'il consiste à réchauffer légèrement le mélange final et à procéder à un écrèmage supplémentaire.  5. Method according to claim 4 characterized in that it consists in slightly reheating the final mixture and in performing an additional skimming.
FR9007158A 1990-06-08 1990-06-08 ANTI-INFLAMMATORY GEL AND ITS MANUFACTURING METHOD. Expired - Lifetime FR2662939B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR9007158A FR2662939B1 (en) 1990-06-08 1990-06-08 ANTI-INFLAMMATORY GEL AND ITS MANUFACTURING METHOD.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9007158A FR2662939B1 (en) 1990-06-08 1990-06-08 ANTI-INFLAMMATORY GEL AND ITS MANUFACTURING METHOD.

Publications (2)

Publication Number Publication Date
FR2662939A1 true FR2662939A1 (en) 1991-12-13
FR2662939B1 FR2662939B1 (en) 1992-09-18

Family

ID=9397419

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9007158A Expired - Lifetime FR2662939B1 (en) 1990-06-08 1990-06-08 ANTI-INFLAMMATORY GEL AND ITS MANUFACTURING METHOD.

Country Status (1)

Country Link
FR (1) FR2662939B1 (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2076903A1 (en) * 1994-04-22 1995-11-01 A M C Fito Capil S Process for obtaining different phytotherapeutic balms for multiple uses.
FR2729859A1 (en) * 1995-01-31 1996-08-02 Rochas Parfums Compsns. contg. essential and/or absolute oil for topical anti-inflammatory treatment
EP0737479A1 (en) * 1991-09-05 1996-10-16 Herta Mag. Haerpfer-Horn Product for care of hide, skin and optionally hoof from animals, in particular from horses
ES2093565A1 (en) * 1995-06-06 1996-12-16 A M C Fito Capil S L Procedure for obtaining a broad-spectrum phytotherapeutic balm.
WO2001095900A1 (en) * 2000-06-15 2001-12-20 Ad 'zdravlje' Farmaceutsko - Hemijska Industrija, Centar Za Istrazivanje I Razvoj Pharmaceutical disinfectants comprising usnic and essential oils
WO2002055096A2 (en) * 2001-01-10 2002-07-18 Walther Schoenenberger Pflanzensaftwerk Gmbh & Co. Kg Local use of essential oils for treating badly healed wounds
EP1275395A2 (en) * 2001-06-07 2003-01-15 Farma-Derma S.R.L. Use of hyaluronic acid for preparing a composition for vaginal use

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3213782A1 (en) * 1982-04-08 1983-10-13 Klein Karl DRUG
FR2543830A1 (en) * 1983-04-11 1984-10-12 Duong Ngoc Xuan Pain-relieving preparation
FR2598615A1 (en) * 1986-05-16 1987-11-20 Grenet Edouard Combination of essential oils and medicaments for the lungs, and applications of this combination as an agent for protecting the airways in the presence of fumes and gases which are harmful to the latter and originate from the combustion of hydrocarbons

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3213782A1 (en) * 1982-04-08 1983-10-13 Klein Karl DRUG
FR2543830A1 (en) * 1983-04-11 1984-10-12 Duong Ngoc Xuan Pain-relieving preparation
FR2598615A1 (en) * 1986-05-16 1987-11-20 Grenet Edouard Combination of essential oils and medicaments for the lungs, and applications of this combination as an agent for protecting the airways in the presence of fumes and gases which are harmful to the latter and originate from the combustion of hydrocarbons

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS vol. 75, no. 26, 27 décembre 1971, page 217, abrégé no. 154993m, Columbus, Ohio, US; R.G. TAMBANE et al.: "Estimation of thymol in analgesic balm" & Indian Journal of Pharmacology 1971, vol. 33, no. 4, pages 70-72 *

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0737479A1 (en) * 1991-09-05 1996-10-16 Herta Mag. Haerpfer-Horn Product for care of hide, skin and optionally hoof from animals, in particular from horses
ES2076903A1 (en) * 1994-04-22 1995-11-01 A M C Fito Capil S Process for obtaining different phytotherapeutic balms for multiple uses.
FR2729859A1 (en) * 1995-01-31 1996-08-02 Rochas Parfums Compsns. contg. essential and/or absolute oil for topical anti-inflammatory treatment
ES2093565A1 (en) * 1995-06-06 1996-12-16 A M C Fito Capil S L Procedure for obtaining a broad-spectrum phytotherapeutic balm.
WO2001095900A1 (en) * 2000-06-15 2001-12-20 Ad 'zdravlje' Farmaceutsko - Hemijska Industrija, Centar Za Istrazivanje I Razvoj Pharmaceutical disinfectants comprising usnic and essential oils
WO2002055096A2 (en) * 2001-01-10 2002-07-18 Walther Schoenenberger Pflanzensaftwerk Gmbh & Co. Kg Local use of essential oils for treating badly healed wounds
WO2002055096A3 (en) * 2001-01-10 2002-11-07 Walter Schoenenberger Pflanzen Local use of essential oils for treating badly healed wounds
EP1275395A2 (en) * 2001-06-07 2003-01-15 Farma-Derma S.R.L. Use of hyaluronic acid for preparing a composition for vaginal use
EP1275395A3 (en) * 2001-06-07 2003-01-22 Farma-Derma S.R.L. Use of hyaluronic acid for preparing a composition for vaginal use

Also Published As

Publication number Publication date
FR2662939B1 (en) 1992-09-18

Similar Documents

Publication Publication Date Title
US6432428B1 (en) Dry emollient composition composing mono-unsaturated jojoba esters
CA1220722A (en) Aqueous or anhydrous cosmetic composition comprising a fatty phase of karite oil
JP2002539268A (en) Stable glycerin-in-oil emulsion
EP1638513B1 (en) Use of a composition comprising unsaponifiable materials
EP0934741B1 (en) Hair growth stimulants
CA2461462A1 (en) Cosmetic composition for human skin and hair care
FR2662939A1 (en) Anti-inflammatory gel and process for producing it
EP0751764B1 (en) Retinal-containing composition
US8383166B2 (en) Stable hydrophobic topical herbal formulationn
FR2746107A1 (en) COMPOSITION THICKENED BY AN ALKYL ETHER OF POLYSACCHARIDE
US8927034B2 (en) High unsaponifiables and methods of using the same
SE515982C2 (en) Use of an oil-in-water emulsion as carrier for preparing a topical cream or lotion
AU718789B2 (en) Formulations for topical use
USRE38141E1 (en) Dry emollient compositions
JP3057207B2 (en) External preparation for skin
JP3445716B2 (en) Transdermal absorption enhancer and external preparation for skin containing the same
EP0957938A1 (en) Composition with base of coconut oil and its use
EP1051979B1 (en) Use of peroxidised lipids to prevent and/or treat the irritating effect of an active agent
JP2004123674A (en) Skin care preparation for external use
JP3170699B2 (en) Cosmetics
RU2088212C1 (en) Cosmetic cream
FR2802810A1 (en) Storage stable topical compositions having an oily phase, a phase in which water is bound to a polymer, and a solvent phase having a matrix material and an easily-oxidizable lipidic compound, for treatment of eczema, erythema, and atopia
SU316451A1 (en) DEPIGMENTATIVE AGENT
RU2108773C1 (en) Face cream "karel"
RU2120275C1 (en) Cream for skin care (versions)

Legal Events

Date Code Title Description
ST Notification of lapse